Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biogen
biotech
boston blog main
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
3
×
fda
indiana blog main
indiana top stories
ipo
3
×
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
venture capital
wisconsin blog main
wisconsin top stories
3
×
boston top stories
cancer
crispr
deerfield management
europe blog main
europe top stories
gilead sciences
melinta therapeutics
startups
What
bio
3
×
ipo
3
×
roundup
covid
medicines
new
years
acquisitions
activity
allogene
announced
approvals
biogen
cancer
ceo
clamped
collabs
crispr
daniel
deal
delays
developing
diversity
economic
fast
fda
gilead
gilead’s
help
hot
immunotherapy
including
introduce
investors
isn’t
juno
lot
million
month
nearly
Language
unset
Current search:
bio
×
ipo
×
" detroit top stories "
×
ipo
×
" wisconsin top stories "
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More